What every parent should know about pfas immunotoxicity (vaccine response)
PFAS immunotoxicity refers to the suppression of immune system function caused by exposure to per- and polyfluoroalkyl substances. The most well-documented effect is reduced antibody response to childhood vaccinations, particularly diphtheria and tetanus. The European Food Safety Authority used immunotoxicity as the critical health endpoint for setting the 2020 PFAS tolerable weekly intake.
Renee · Founder & Lead Researcher, R3
We score every product the same way and never accept brand payment. We may earn a commission from some links, which never changes a score. How we stay independent.
Quick facts
Get the research before you buy
New picks and safety research, no spam, no sponsors.
Of all the health effects attributed to PFAS, immunotoxicity might be the most consequential for families - and it is arguably the best-documented. The landmark Faroe Islands studies showed that children with higher PFAS blood levels produced fewer antibodies after routine childhood vaccinations. This finding was so robust that the European Food Safety Authority chose immune suppression as the critical endpoint for setting PFAS safety limits for the entire European population.
For parents navigating vaccination schedules and trying to give their children the best immune protection possible, this research deserves a close look.
The research that changed how regulators think about PFAS and the immune system comes primarily from the Faroe Islands - a small Danish archipelago in the North Atlantic where residents have elevated PFAS exposure through their seafood-heavy diet.
Philippe Grandjean and colleagues at Harvard T.H. Chan School of Public Health followed two birth cohorts in the Faroes, measuring PFAS blood levels at ages 5 and 7 and comparing them to antibody concentrations after routine diphtheria and tetanus vaccinations.
The findings, published in JAMA in 2012, were striking:
This means that some children with high PFAS exposure may not achieve adequate immune protection from vaccines they received on schedule. They got the shots, but their immune systems could not mount a strong enough response.
A follow-up study in 2017 extended these findings to age 13, showing that the immune suppression effect persisted through adolescence. The association was not limited to PFOS - PFOA and other PFAS compounds also showed inverse associations with vaccine antibody response.
In 2020, the European Food Safety Authority published its updated risk assessment for PFAS and made a decision that surprised many observers: instead of using liver toxicity, cancer, or reproductive effects as the critical health endpoint, EFSA chose vaccine antibody response in children.
The reasoning was sound. Immunotoxicity occurred at lower PFAS exposure levels than other health effects. The Faroe Islands data showed measurable immune suppression at blood PFAS concentrations found in the general European population - not just in heavily contaminated communities. This made it the most sensitive endpoint and therefore the most health-protective basis for setting exposure limits.
EFSA set a tolerable weekly intake (TWI) of 4.4 ng/kg body weight per week for the sum of four PFAS: PFOA, PFOS, PFHxS, and PFNA. This is dramatically lower than previous safety thresholds and reflects how seriously European regulators assessed the immunotoxicity evidence.
For context, a substantial portion of the European population exceeds this TWI based on routine dietary and water exposure. The limit essentially says: the current level of PFAS exposure in ordinary life is already high enough to affect children's immune function.
In 2016, the US National Toxicology Program published a systematic review evaluating whether PFOA and PFOS are immune hazards to humans. After assessing all available human and animal evidence, the NTP reached the following conclusions:
The NTP review considered not just vaccine response but also susceptibility to infectious disease, autoimmune effects, and allergic sensitization. The vaccine antibody data was the strongest line of evidence, but the broader immune suppression picture was consistent across multiple study types.
The mechanisms behind PFAS immunotoxicity involve multiple arms of the immune system.
PFAS interfere with B cell function - the immune cells responsible for producing antibodies. In animal studies, PFOS and PFOA exposure reduces the number and activity of B cells in the spleen and bone marrow. In human studies, this translates to lower immunoglobulin levels and reduced specific antibody production after vaccination or natural infection.
T cells coordinate the immune response and are essential for B cells to produce high-quality antibodies. PFAS exposure has been shown to alter T helper cell ratios (Th1/Th2 balance), reduce T cell proliferation in response to immune challenges, and impair the development of memory T cells that provide long-term immunity.
Natural killer (NK) cells are the immune system's first line of defense against virus-infected cells and early cancer cells. Studies have found that PFAS exposure reduces NK cell activity. This has implications not only for vaccine response but for broader susceptibility to infections and for the immune surveillance that catches cancerous cells early - connecting to PFAS cancer risk.
Animal studies show that PFAS exposure causes thymic atrophy - shrinkage of the thymus, the organ where T cells mature. A smaller, less functional thymus produces fewer and less effective T cells, creating downstream immune suppression that affects virtually every arm of adaptive immunity.
The practical significance of PFAS immunotoxicity is most direct for children, and here is why.
The pediatric vaccination schedule is designed with specific timing based on when children need immune protection and when their immune systems are developmentally ready to respond. Vaccines work by training the immune system to recognize specific pathogens and produce antibodies that provide future protection.
If PFAS exposure reduces a child's ability to mount an adequate antibody response, it can mean:
This does not mean vaccines "don't work" for PFAS-exposed children. It means the immune response may be blunted - the child gets some protection but potentially not the full level that the vaccine is designed to deliver.
For parents who are diligent about following vaccination schedules, the idea that an environmental chemical exposure could undermine that effort is understandably frustrating. It adds another dimension to the case for reducing PFAS exposure in early childhood.
Some epidemiological studies have found associations between PFAS exposure and increased frequency of common infections in children - including upper respiratory infections, gastroenteritis, and ear infections. The evidence here is less consistent than the vaccine data but aligns with the mechanistic picture of broadly suppressed immune function.
The PFAS immune picture is complex. While PFAS suppress some immune functions (antibody production, T cell response), they may dysregulate others. Some studies have found associations between PFAS exposure and increased risk of asthma, eczema, and food allergies in children - suggesting that PFAS may shift the immune balance rather than simply suppressing it. The NTP review acknowledged this complexity but noted that the immunosuppressive evidence was more consistent and robust.
Adults are not exempt. Studies have found associations between higher PFAS blood levels and reduced influenza vaccine antibody response in adults, and reduced immune function in occupationally exposed workers. The PFAS body burden entry covers how cumulative exposure affects long-term immune health across the lifespan.
For reducing children's PFAS-driven immune suppression, the same exposure hierarchy applies as for other PFAS health effects.
Drinking water is the largest single source for most families. Children consume more water relative to body weight than adults, making them proportionally more exposed. Formula-fed infants whose formula is mixed with PFAS-contaminated tap water face the highest per-body-weight exposure. An NSF/ANSI 58-certified reverse osmosis filter or NSF/ANSI 53/P473-certified carbon block filter addresses this source.
Diet contributes through contaminated food packaging, seafood from contaminated waters, and to some extent through food grown with contaminated water or biosolids. Cooking at home with fresh ingredients and reducing fast-food packaging exposure helps.
Consumer products including older nonstick cookware, air fryers with pre-2015 or damaged PTFE coatings, stain-resistant furniture and carpeting, and certain personal care products all contribute to the total PFAS body burden. For cookware specifically, replacing damaged nonstick items with stainless steel, ceramic-coated, or cast iron alternatives eliminates one ongoing exposure source.
For families with young children on active vaccination schedules, reducing PFAS exposure supports the strongest possible vaccine response. Check air fryer baskets and cookware for coating condition - pre-2015 or scratched PTFE coatings can release PFAS into food. If you prepare baby formula or toddler drinks with tap water, verify your water's PFAS status and use a certified filter if levels exceed 4 ppt. These small steps help ensure your child's immune system can respond to vaccines as effectively as possible.
PFAS immunotoxicity is the best-documented low-dose PFAS health effect and was selected by EFSA as the critical endpoint for setting the 2020 PFAS tolerable weekly intake of 4.4 ng/kg/week.
Vaccine response: The Faroe Islands studies found that each doubling of serum PFOS at age 5 was associated with 49% lower diphtheria antibody and 36% lower tetanus antibody levels. Children with higher PFAS were more likely to fall below clinically protective thresholds. Effects persisted to age 13.
NTP assessment: Both PFOA and PFOS classified as "presumed immune hazards to humans" based on systematic review of all available evidence.
Mechanisms: Suppressed B cell antibody production, impaired T cell function and memory development, reduced NK cell activity, and thymic atrophy documented in both animal models and human studies.
Broader immune effects: Associations with increased childhood infections, potential allergic sensitization, and reduced adult vaccine responses. The immune suppression pathway also contributes to cancer risk by reducing immune surveillance against malignant cells.
EFSA (2020): Set PFAS TWI at 4.4 ng/kg body weight/week based on immunotoxicity as the critical endpoint. This is the most health-protective PFAS limit set by any major regulatory body.
US NTP (2016): Classified PFOS as "presumed immune hazard to humans" (high confidence) and PFOA as "presumed immune hazard to humans" (moderate confidence).
US EPA (2024): Finalized MCLs of 4 ppt for PFOA and PFOS in drinking water. MCLG set at zero. Compliance deadline 2029.
State Level: Multiple US states have set drinking water standards more stringent than federal MCLs, with some referencing the immune suppression evidence. Minnesota banned PFAS in cookware effective January 2025.
WHO/IARC (2023): While focused on cancer classification, the IARC monograph acknowledged immunosuppression as a key characteristic of PFAS carcinogenicity.
Who is most at risk
When to seek medical attention
If your child has completed their vaccination series but you are concerned about PFAS-related immune suppression, discuss with your pediatrician whether checking vaccine antibody titers (blood tests measuring specific antibody levels) is appropriate. If you live near a PFAS contamination site and your child seems to get sick frequently, mention your location and potential PFAS exposure to your pediatrician. For adults with known high PFAS exposure who receive annual influenza or other vaccines, discussing antibody response monitoring with your primary care provider is reasonable.
How to spot it on labels
No product label addresses immunotoxicity specifically. Reduce exposure by looking for PTFE-free AND PFAS-free stated together on cookware, air fryers, and food-contact products. For water filters, verify NSF/ANSI 58 (reverse osmosis) or NSF/ANSI 53/P473 (carbon block) certification at nsf.org by model number. For baby bottles and sippy cups, look for PFAS-free certifications and avoid products with questionable nonstick coatings.
What this does NOT cover
Vaccine safety or vaccine composition - PFAS immunotoxicity is about the body's response to vaccines, not about the vaccines themselves Other environmental chemicals that affect immune function (lead, mercury, dioxins, pesticides) Clinical immunodeficiency disorders unrelated to chemical exposure Detailed vaccination schedule recommendations (consult your pediatrician and CDC guidelines) Autoimmune conditions beyond what is briefly mentioned regarding immune dysregulation
How to verify
For drinking water: check your utility's Consumer Confidence Report or search EWG's Tap Water Database at ewg.org/tapwater. This is especially important if you mix infant formula with tap water. For private wells, test through an NSF-certified laboratory. For cookware and air fryers: contact the manufacturer and request total organic fluorine test results. For personal PFAS levels: blood testing is available through Quest Diagnostics and LabCorp, though there are no established clinical thresholds for immune function.
PFOS
Strongest immunotoxicity evidence. NTP: "presumed immune hazard" (high confidence). Faroe Islands: 49% diphtheria antibody reduction per serum doubling at age 5.
PFOA
NTP: "presumed immune hazard" (moderate confidence). Faroe Islands data shows significant vaccine antibody associations. IARC cited immunosuppression in cancer classification.
PFHxS
Included in EFSA's 4-compound TWI. Some immune association data but less studied individually than PFOS and PFOA.
PFNA
Included in EFSA's TWI. Emerging immune data supports inclusion in the PFAS immunotoxicity profile.
What this means for your family
Every product scored on safety, efficacy, and usability - so you know which products to trust around pfas immunotoxicity (vaccine response).
Get the Air Fryer shortlist, free
The picks that cleared safety, what to skip, and why price didn’t predict the winner.
No spam. Unsubscribe any time.
No. PFAS exposure reduces the antibody response to vaccines but does not eliminate it entirely. Most children will still achieve protective immunity from their vaccinations. The concern is that some children with higher PFAS exposure may produce antibody levels closer to or below the clinically protective threshold, potentially reducing the duration or strength of their immunity. Continue following recommended vaccination schedules - vaccines remain the most effective protection against infectious diseases.
The Faroe Islands studies documented effects on diphtheria and tetanus vaccine antibody responses most clearly. Additional research has found associations with rubella vaccine response in children and influenza vaccine response in adults. The immune suppression mechanisms (reduced B cell and T cell function) suggest that the effect is likely not limited to specific vaccines - PFAS suppress the general ability to produce antibodies in response to immune challenges.
The Faroe Islands vaccine response data was so compelling that EFSA chose it as the critical health endpoint for setting the 2020 PFAS tolerable weekly intake of 4.4 ng/kg body weight per week. This is the most stringent PFAS safety limit set by any major regulatory body. EFSA's reasoning was that immune suppression occurred at lower PFAS exposures than other health effects, making it the most sensitive and protective basis for safety limits.
Blood PFAS testing is available but is not part of routine pediatric care. It may be worth discussing with your pediatrician if you live near a known PFAS contamination site, your drinking water has tested above EPA MCLs, or your child has had an unusual pattern of infections or poor vaccine response. There are currently no established clinical thresholds that trigger specific medical interventions, but the results can inform personal decisions about exposure reduction priorities.
Cookware and air fryers are one source of PFAS exposure, but typically not the largest for most families. Drinking water and diet generally contribute more to total PFAS body burden. That said, if your air fryer has a damaged PTFE coating (especially pre-2015 models), it does add to cumulative exposure. Replacing it with a stainless steel or ceramic basket option eliminates one source. For children's immune health, addressing drinking water quality is the highest priority.
Both routes carry some PFAS exposure. Formula mixed with PFAS-contaminated tap water can deliver significant PFAS to infants. Breast milk also transfers PFAS from parent to infant. However, breast milk provides immune factors (antibodies, immune cells, beneficial bacteria) that support infant immune development in ways that formula cannot replicate. All major health organizations recommend breastfeeding despite PFAS transfer. If formula-feeding, use filtered water (NSF/ANSI 58 or 53/P473-certified) to prepare formula.
PFAS have long half-lives in the body (PFOS: 3-8 years, PFOA: 2-4 years), so blood levels decline slowly after exposure reduction. As PFAS levels decrease over time, immune function is expected to recover, though the timeline depends on how elevated the levels were. The most effective strategy is reducing ongoing exposure sources so that blood levels can decline naturally. There is no medication or supplement proven to accelerate PFAS elimination from the body.
The vaccine response data is the most quantifiable evidence of PFAS immunotoxicity, but the immune effects extend beyond vaccination.
Breast milk transfers PFAS from parent to infant and is a significant early-life exposure route. However, the health benefits of breastfeeding are well-established and all major health organizations recommend breastfeeding despite PFAS transfer. Reducing the parent's PFAS exposure sources reduces what passes through breast milk.
The immunotoxicity evidence does not mean that PFAS make vaccines useless or that children are unprotected. It means that at the population level, PFAS exposure reduces the average immune response to vaccination, and some children at the higher end of exposure may fall below clinically protective antibody thresholds.
The most effective response is reducing PFAS exposure sources - especially drinking water and dietary sources for infants and young children - while continuing to follow recommended vaccination schedules. Vaccines remain the most effective tool for preventing infectious disease. The goal is to ensure children's immune systems can respond to those vaccines as effectively as possible by minimizing the chemical interference that PFAS represent.